LG Chem
Clinical trials sponsored by LG Chem, explained in plain language.
A major South Korean chemical and pharmaceutical company, subsidiary of LG Corp.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can one shot replace six? a new vaccine aims to protect infants from six diseases at once
Vaccine CompletedResearchers are testing a new vaccine called LBVD that combines protection against diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib into a single injection. The study will enroll healthy infants aged 6 to 8 weeks, who will receive three doses at 6, 10, and 14 week…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
New combo pill may help diabetes patients control blood sugar
Disease control CompletedThis completed observational study looked at over 2,000 adults with type 2 diabetes who were already taking metformin plus another diabetes drug. Researchers wanted to see if adding a new combination pill called Zemidapa (which contains two diabetes medicines) could improve blood…
Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if different doses could safely lower uric acid below target levels over 12 weeks. Participants took the drug or a placebo, and researchers measured uric acid in the b…
Phase 2 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid. Participants took one of three doses or a placebo for 6 months. The main goal was to see if the drug could keep uric acid below a target level. The trial is complete and results will …
Phase 3 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Will breakfast change how this diabetes drug works?
Knowledge-focused CompletedThis early-stage trial in 28 healthy adults tests whether eating a meal changes how the body absorbs a single tablet containing three diabetes medicines (gemigliptin, dapagliflozin, and metformin). Participants take the pill once while fasting and once after a meal, and researche…
Phase 1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New triple diabetes pill tested in healthy adults
Knowledge-focused CompletedThis study looks at how a new pill that combines three diabetes medicines (gemigliptin, dapagliflozin, and metformin) works in healthy adults. About 58 people will take either the new combination pill or the three drugs separately, then switch. The goal is to see if the combinati…
Phase 1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
One pill to replace three? diabetes combo drug tested
Knowledge-focused CompletedThis study tested whether a single pill containing three diabetes medicines (gemigliptin, dapagliflozin, and metformin) works the same in the body as taking them separately. Fifty healthy adults took either the combo pill or the separate drugs after a meal, and researchers measur…
Phase 1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC